|
1
|
International Agency for Research on
Cancer. GLOBOCAN 2008: Stomach cancer incidence, mortality and
prevalence worldwide in 2008 summary. http://globocan.iarc.fr/factsheet.asp.
Accessed February 25, 2013
|
|
2
|
Coleman MP, Estève J, Damiecki P, Arslan A
and Renard H: Trends in cancer incidence and mortality. IARC Sci
Publ; pp. 1–806. 1993
|
|
3
|
Muir CS, Waterhouse J, Mack T, Powell J
and Whelan S: Cancer Incidence in Five Continents. 5. IARC
Scientific Publications no. 88. IARC Press; Lyon: 1987
|
|
4
|
Parkin DM, Muir CS, Whelan SL, Gao YT,
Ferlay J and Powell J: Cancer Incidence in Five Continents. 6. IARC
Scientific Publications no. 120. IARC Press; Lyon: 1992
|
|
5
|
Muñoz N and Asvall J: Time trends of
intestinal and diffuse types of gastric cancer in Norway. Int J
Cancer. 8:144–157. 1971.
|
|
6
|
Kram A, Peychewa M, Bachurska S and
Domagala W: Morphometric distinction of signet-ring cell
adenocarcinoma cells from foamy macrophages in gastric endoscopic
biopsies. Pol J Pathol. 62:145–147. 2011.PubMed/NCBI
|
|
7
|
Dziewulska-Bokiniec. Nowotwory narządów
trawiennych. Zarys Chirurgii Onkologicznej. Kopacz A: Akademia
Medyczna w Gdańsku; Gdańsku: pp. 1712000, (In Polish).
|
|
8
|
Krawczyk M: Gastrointestinal Cancers. 46.
Wydawnictwo Lekarskie PZWL; Warsaw: pp. 153–155. 2001, (In
Polish).
|
|
9
|
Godlewski J, Kuciel-Lisieska G, Licznerska
G and Tenderenda M: Left-sided renal colic as a symptom of advanced
stomach cancer - a case report. Wspolczesna Onkol. 16:191–193.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ferlay J, Bray F, Pisani P, et al:
GLOBOCAN 2000: Cancer incidence, mortality and prevalance
worldwide, version 1.0. IARC Cancer Base no. 5. IARC Press; Lyon:
2001
|
|
11
|
Oota K and Sobin LH: Histological typing
of gastric and oesophageal tumors. International Histological
Classification of Tumours. (18)World Health Organisation; Geneva:
1977
|
|
12
|
Borrmann R: Tumors of the stomach and
duodenum. Handbook of Specific Pathological Anatomy and Histology.
Henke F and Lubarsch O: 4. Springer-Verlag; Berlin: pp. 8651926,
(In German).
|
|
13
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965.
|
|
14
|
Ming SC: Gastric carcinoma. A
pathobiological classification. Cancer. 39:2475–2485. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Japanese Gastric Cancer Association.
Japanese classification of gastric carcinoma: 3rd English edition.
Gastric Cancer. 14:101–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakamura K, Ueyama T, Yao T, et al:
Pathology and prognosis of gastric carcinoma. Findings in 10,000
patients who underwent primary gastrectomy. Cancer. 70:1030–1037.
1992. View Article : Google Scholar
|
|
17
|
Hirota T, Ming SC and Itabashi M:
Pathology of early gastric cancer. Gastric Cancer. Springer-Verlag;
Tokyo: pp. 66–85. 1993, View Article : Google Scholar
|
|
18
|
Murakami T: Pathomorphological diagnosis.
Definition and gross classification of early gastric cancer. Gann
Monogr Cancer Res. 11:53–55. 1971.
|
|
19
|
Tsukuma H, Oshima A, Narahara H and Morii
T: Natural history of early gastric cancer: a non-concurrent, long
term, follow up study. Gut. 47:618–621. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fenoglio-Preiser CM, Noffsinger AE, Belli
J and Stemmermann GN: Pathologic and phenotypic features of gastric
cancer. Semin Oncol. 23:292–306. 1996.PubMed/NCBI
|
|
21
|
Ahn HS, Lee HJ, Yoo MW, et al: Changes in
clinicopathological features and survival after gastrectomy for
gastric cancer over a 20-year period. Br J Surg. 98:255–260.
2011.PubMed/NCBI
|
|
22
|
Xue N, Huang P, Aronow WS, Wang Z, Nair
CK, Zheng Z, Shen X, Yin Y, Huang F and Cosgrove D: Predicting
lymph node status in patients with early gastric carcinoma using
double contrast-enhanced ultrasonography. Arch Med Sci. 7:457–464.
2011. View Article : Google Scholar
|
|
23
|
Ott K, Sendler A, Becker K, et al:
Neoadjuvant chemotherapy with cisplatin, 5-FU and leucovorin (PLF)
in locally advanced gastric cancer: a prospective phase II study.
Gastric Cancer. 6:159–167. 2003. View Article : Google Scholar
|
|
24
|
Scaringi S, Kianmanesh R, Sabate JM, et
al: Advanced gastric cancer with or without peritoneal
carcinomatosis treated with hyperthermic intraperitoneal
chemotherapy: a single western center experience. Eur J Surg Oncol.
34:1246–1252. 2008. View Article : Google Scholar
|
|
25
|
Schuhmacher CP, Fink U, Becker K, et al:
Neoadjuvant therapy for patients with locally advanced gastric
carcinoma with etoposide, doxorubicin and cisplatinum. Closing
results after 5 years of follow-up. Cancer. 91:918–927. 2001.
|
|
26
|
Bataille F, Rümmele P, Dietmaier W, et al:
Alterations in p53 predict response to preoperative high dose
chemotherapy in patients with gastric cancer. Mol Pathol.
56:286–292. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Carboni F, Lepiane P, Santoro R, Mancini
P, Lorusso R and Santoro E: Laparoscopic surgery for gastric
cancer: preliminary experience. Gastric Cancer. 8:75–77. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luinetti O, Fiocca R, Villani L, Alberizzi
P, Ranzani GN and Solcia E: Genetic pattern, histological structure
and cellular phenotype in early and advanced gastric cancers:
evidence for structure-related genetic subsets and for loss of
glandular structure during progression of some tumors. Hum Pathol.
29:702–709. 1998. View Article : Google Scholar
|
|
29
|
Theuer CP, Campbell BS, Peel DJ, et al:
Microsatellite instability in Japanese vs European American
patients with gastric cancer. Arch Surg. 137:960–966. 2002.
View Article : Google Scholar
|
|
30
|
Orditura M, De Vita F, Muto P, et al:
Adjuvant chemoradiotherapy in patients with stage III or IV
radically resected gastric cancer: a pilot study. Arch Surg.
145:233–238. 2010. View Article : Google Scholar
|
|
31
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th edition.
Springer; New York: 2010
|
|
32
|
Kim HH, Hyung WJ, Cho GS, et al: Morbidity
and mortality of laparoscopic gastrectomy versus open gastrectomy
for gastric cancer: an interim report - a phase III multicenter,
prospective, randomized Trial (KLASS Trial). Ann Surg. 251:417–420.
2010. View Article : Google Scholar
|
|
33
|
Han S-K: Efficacy of laparoscopic subtotal
gastrectomy with D2 lymph node dissection for locally advanced
gastric cancer (KLASS-02-RCT). NCT01456598. http://clinicaltrials.gov/ct2/show/NCT0145659.
Verified July, 2012.
|
|
34
|
Chiaravalli AM, Cornaggia M, Furlan D,
Capella C, Fiocca R, Tagliabue G, Klersy C and Solcia E: The role
of histological investigation in prognostic evaluation of advanced
gastric cancer. Analysis of histological structure and molecular
changes compared with invasive pattern and stage. Virchows Arch.
439:158–169. 2011. View Article : Google Scholar
|
|
35
|
MacDonald WC, Owen DA and Le N: Chronic
advanced gastric cancer: clinicopathologic analysis of survival
data. Hum Pathol. 39:641–649. 2008. View Article : Google Scholar
|
|
36
|
Piso P, Werner U, Lang H, Mirena P and
Klempnauer J: Proximal versus distal gastric carcinoma - what are
the differences? Ann Surg Oncol. 7:520–525. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zilberstein B, da Costa Martins B, Jacob
CE, et al: Complications of gastrectomy with lymphadenectomy in
gastric cancer. Gastric Cancer. 7:254–259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Doglietto GB, Pacelli F, Caprino P,
Sgadari A and Crucitti F: Surgery: independent prognostic factor in
curable and far advanced gastric cancer. World J Surg. 24:459–463.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Piessen G, Messager M, Leteurtre E,
Jean-Pierre T and Mariette C: Signet ring cell histology is an
independent predictor of poor prognosis in gastric adenocarcinoma
regardless of tumoral clinical presentation. Ann Surg. 250:878–887.
2009. View Article : Google Scholar
|
|
40
|
Soyuer S, Soyuer I, Unal D, Ucar K, Yildiz
OG and Orhan O: Prognostic significance of CD9 expression in
locally advanced gastric cancer treated with surgery and adjuvant
chemoradiotherapy. Pathol Res Pract. 206:607–610. 2010. View Article : Google Scholar
|
|
41
|
Wirtz HC, Müller W, Noguchi T, Scheven M,
Rüschoff J, Hommel G and Gabbert HE: Prognostic value and
clinopathological profile of microsatellite instability in gastric
cancer. Clin Cancer Res. 4:1749–1754. 1998.PubMed/NCBI
|
